ADUS Director Awarded 1,172 Restricted Shares on 6/18/25 Form 4

On June 18, 2025, Director Susan T. Weaver reported the acquisition of 1,172 restricted shares of Addus HomeCare Corp. (ADUS) common stock, coded “A” on Form 4, indicating an award or grant from the issuer with no cash consideration ($0 price).

Rhea-AI Filing Summary

On June 18, 2025, Director Susan T. Weaver reported the acquisition of 1,172 restricted shares of Addus HomeCare Corp. (ADUS) common stock, coded “A” on Form 4, indicating an award or grant from the issuer with no cash consideration ($0 price). The shares will vest in full on June 18, 2026. Following the grant, Weaver’s direct beneficial ownership rises to 12,295 shares. No shares were sold, and no derivative securities were involved. The filing was signed on June 20, 2025 by Attorney-in-Fact Brian Poff.

Insights

Securities Analyst

TL;DR: Minor insider stock grant; neutral market impact.

The transaction adds a small 1,172-share award to a director’s holdings, bringing total ownership to 12,295 shares. Because it is a routine, no-cost equity grant that does not involve open-market buying or selling, it conveys neither bullish nor bearish sentiment. The size is immaterial relative to ADUS’s public float, so I classify the market impact as neutral.

Corporate Governance Expert

TL;DR: Standard non-employee director compensation; governance status quo.

The one-year vesting aligns with typical board compensation plans and supports long-term alignment without creating immediate dilution pressure. No red flags or unusual structures are present, keeping governance risk unchanged. Therefore, the disclosure is not impactful for strategic or compliance considerations.

Insider Trade Summary

Grant/Award: 1,172 shares

Grant/Award 1 txn

Insider Weaver Susan T

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,172	$0.00	$0.00

Holdings After Transaction: Common Stock — 12,295 shares (Direct)

Footnotes (1)

1. F1. Restricted shares granted to non-employee directors that will vest in full on June 18, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ADUS shares did Susan T. Weaver acquire in the Form 4?

She acquired 1,172 restricted shares of Addus HomeCare common stock.

What transaction code was used in the ADUS Form 4 filing?

The filing shows transaction code "A", indicating an award or grant.

When will the restricted ADUS shares vest?

The shares will vest in full on June 18, 2026.

What is Susan Weaver’s total direct ownership after the grant?

Her direct beneficial ownership increased to 12,295 shares.

Were any ADUS shares sold or disposed of in this Form 4?

No. The filing only reports an acquisition; no sales were disclosed.

When was the Form 4 for ADUS filed?

The Form 4 was signed and filed on June 20, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/20/2025 - 04:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Weaver Susan T

(Last) (First) (Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO TX 75034

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/18/2025		A		1,172(1)	A	$0	12,295	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted shares granted to non-employee directors that will vest in full on June 18, 2026.

	/s/ Brian Poff, Attorney-In-Fact for Susan T. Weaver	06/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.